Wednesday, November 22, 2017

British Journal of Cancer - Table of Contents alert Volume 117 Issue 11

If you are unable to see the message below, click here to view.
British Journal of Cancer
TABLE OF CONTENTS

Volume 117, Issue 11 (1581-1731)
Published online 21 November 2017
 

In this issue
Editorial
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology

Also new today
Advance online publication
Digital Edition
 
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Editorial

Top

Morphomolecular pathology: setting the framework for a new generation of pathologists

J Louise Jones, Karin A Oien, Jessica L Lee and Manuel Salto-Tellez

Br J Cancer 2017 117: 1581-1582; advance online publication, November 9, 2017; 10.1038/bjc.2017.340

Full Text

Minireview

Top

TAMeless traitors: macrophages in cancer progression and metastasis

Shweta Aras and M Raza Zaidi

Br J Cancer 2017 117: 1583-1591; advance online publication, October 24, 2017; 10.1038/bjc.2017.356

Abstract | Full Text

Clinical Studies

Top

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours

K P Papadopoulos, B F El-Rayes, A W Tolcher, A Patnaik, D W Rasco, R D Harvey, P M LoRusso, J C Sachdev, G Abbadessa, R E Savage, T Hall, B Schwartz, Y Wang, J Kazakin and W L Shaib

Br J Cancer 2017 117: 1592-1599; advance online publication, October 3, 2017; 10.1038/bjc.2017.330

Abstract | Full Text

IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer

Tamara Aleksic, Clare Verrill, Richard J Bryant, Cheng Han, Andrew Ross Worrall, Laurent Brureau, Stephane Larré, Geoff S Higgins, Fahad Fazal, Ahmad Sabbagh, Syed Haider, Francesca M Buffa, David Cole and Valentine M Macaulay

Br J Cancer 2017 117: 1600-1606; advance online publication, October 3, 2017; 10.1038/bjc.2017.337

Abstract | Full Text

The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study

Hiroyuki Sakae, Hiromitsu Kanzaki, Junichiro Nasu, Yutaka Akimoto, Kazuhiro Matsueda, Masao Yoshioka, Masahiro Nakagawa, Shinichiro Hori, Masafumi Inoue, Tomoki Inaba, Atsushi Imagawa, Masahiro Takatani, Ryuta Takenaka, Seiyu Suzuki, Toshiyoshi Fujiwara and Hiroyuki Okada

Br J Cancer 2017 117: 1607-1613; advance online publication, October 5, 2017; 10.1038/bjc.2017.338

Abstract | Full Text

Dose–response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial

Justin C Brown, Babette S Zemel, Andrea B Troxel, Michael R Rickels, Nevena Damjanov, Bonnie Ky, Andrew D Rhim, Anil K Rustgi, Kerry S Courneya and Kathryn H Schmitz

Br J Cancer 2017 117: 1614-1620; advance online publication, September 21, 2017; 10.1038/bjc.2017.339

Abstract | Full Text

Translational Therapeutics

Top

Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1

Zhongya Ni, Chao Yao, Xiaowen Zhu, Chenyuan Gong, Zihang Xu, Lixin Wang, Suyun Li, Chunpu Zou and Shiguo Zhu

Br J Cancer 2017 117: 1621-1630; advance online publication, October 12, 2017; 10.1038/bjc.2017.319

Abstract | Full Text

A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma

Wei Sun, Fan-Qin Wei, Wei-Jin Li, Jia-Wei Wei, Hua Zhong, Yi-Hui Wen, Wen-Bin Lei, Lin Chen, Hang Li, Han-Qing Lin, Muhammad Iqbal and Wei-Ping Wen

Br J Cancer 2017 117: 1631-1643; advance online publication, September 26, 2017; 10.1038/bjc.2017.329

Abstract | Full Text

Interleukin-10-regulated tumour tolerance in non-small cell lung cancer

Julius Malte Vahl, Juliane Friedrich, Susanne Mittler, Sonja Trump, Lisanne Heim, Katerina Kachler, Liubov Balabko, Nicole Fuhrich, Carol-Immanuel Geppert, Denis Iulian Trufa, Nina Sopel, Ralf Rieker, Horia Sirbu and Susetta Finotto

Br J Cancer 2017 117: 1644-1655; advance online publication, October 10, 2017; 10.1038/bjc.2017.336

Abstract | Full Text

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

Peder R Braadland, Guro Giskeødegård, Elise Sandsmark, Helena Bertilsson, Leslie R Euceda, Ailin F Hansen, Ingrid J Guldvik, Kirsten M Selnæs, Helene H Grytli, Betina Katz, Aud Svindland, Tone F Bathen, Lars M Eri, Ståle Nygård, Viktor Berge, Kristin A Taskén and May-Britt Tessem

Br J Cancer 2017 117: 1656-1664; advance online publication, October 3, 2017; 10.1038/bjc.2017.346

Abstract | Full Text

Molecular Diagnostics

Top

Glucose insult elicits hyperactivation of cancer stem cells through miR-424–cdc42–prdm14 signalling axis

Sushmita Bose Nandy, Alexis Orozco, Rebecca Lopez-Valdez, Rene Roberts, Ramadevi Subramani, Arunkumar Arumugam, Alok Kumar Dwivedi, Viktoria Stewart, Gautham Prabhakar, Stephanie Jones and Rajkumar Lakshmanaswamy

Br J Cancer 2017 117: 1665-1675; advance online publication, October 12, 2017; 10.1038/bjc.2017.335

Abstract | Full Text

In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery

Jian Zhang, Ning Hao, Wei Liu, Min Lu, Longqin Sun, Ning Chen, Miantao Wu, Xiaohang Zhao, Baocai Xing, Wei Sun and Fuchu He

Br J Cancer 2017 117: 1676-1684; advance online publication, October 12, 2017; 10.1038/bjc.2017.344

Abstract | Full Text

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

Carlo Visco, Jinfen Wang, Maria Chiara Tisi, Lijuan Deng, Emanuele S G D'Amore, Alexandar Tzankov, Santiago Montes-Moreno, Karen Dybkær, Govind Bhagat, Eric D Hsi, J Han van Krieken, Maurilio Ponzoni, Andrés J M Ferreri, Michael B Møller, Miguel A Piris, L Jeffrey Medeiros, Zijun Y Xu-Monette and Ken H Young

Br J Cancer 2017 117: 1685-1688; advance online publication, September 26, 2017; 10.1038/bjc.2017.345

Abstract | Full Text

Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence

Elisabeth Letellier, Martine Schmitz, Aurélien Ginolhac, Fabien Rodriguez, Pit Ullmann, Komal Qureshi-Baig, Sonia Frasquilho, Laurent Antunes and Serge Haan

Br J Cancer 2017 117: 1689-1701; advance online publication, October 12, 2017; 10.1038/bjc.2017.352

Abstract | Full Text

Genetics & Genomics

Top

Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types

Christina Therkildsen, Steen Ladelund, Lars Smith-Hansen, Lars Joachim Lindberg and Mef Nilbert

Br J Cancer 2017 117: 1702-1710; advance online publication, October 24, 2017; 10.1038/bjc.2017.348

Abstract | Full Text

Epidemiology

Top

Disability and participation in breast and bowel cancer screening in England: a large prospective study

S Floud, I Barnes, M Verfürden, H Kuper, T Gathani, R G Blanks, R Alison, J Patnick, V Beral, J Green and G K Reeves for the Million Women Study Collaborators

Br J Cancer 2017 117: 1711-1714; advance online publication, October 3, 2017; 10.1038/bjc.2017.331

Abstract | Full Text

Body mass index change during adulthood and risk of oesophageal squamous-cell carcinoma in a Japanese population: the Japan Public Health (JPHC)-based prospective study

Huan Song, Eiko Saito, Norie Sawada, Sarah K Abe, Akihisa Hidaka, Taichi Shimazu, Taiki Yamaji, Atsushi Goto, Motoki Iwasaki, Shizuka Sasazuki, Weimin Ye, Manami Inoue and Shoichiro Tsugane for the Japan Public Health Center-based Prospective Study group

Br J Cancer 2017 117: 1715-1722; advance online publication, September 26, 2017; 10.1038/bjc.2017.332

Abstract | Full Text

Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up

Clare Frobisher, Adam Glaser, Gill A Levitt, David J Cutter, David L Winter, Emma R Lancashire, Kevin C Oeffinger, Joyeeta Guha, Julie Kelly, Raoul C Reulen and Michael M Hawkins on behalf of the National Cancer Survivorship Initiative (NCSI) and the British Childhood Cancer Survivor Study (BCCSS) Steering Group

Br J Cancer 2017 117: 1723-1731; advance online publication, October 24, 2017; 10.1038/bjc.2017.347

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: